Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.300
+0.060 (1.85%)
Mar 3, 2026, 4:00 PM EST - Market closed
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $155.52 million as of March 3, 2026. Its market cap has increased by 143.63% in one year.
Market Cap
155.52M
Enterprise Value
-7.07M
1-Year Change
143.63%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $155.52M, a decrease of -71.24%. That is a compound annual growth rate of -24.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 155.52M | 36.36% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 169.14M |
| Rani Therapeutics Holdings | 166.48M |
| ProQR Therapeutics | 165.92M |
| Innate Pharma | 162.13M |
| Zentalis Pharmaceuticals | 159.93M |
| Sangamo Therapeutics | 159.45M |
| Corbus Pharmaceuticals Holdings | 156.38M |
| Unicycive Therapeutics | 147.43M |